PRME
Price
$1.41
Change
-$0.21 (-13.04%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
211.17M
34 days until earnings call
RXRX
Price
$4.24
Change
-$0.57 (-11.85%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
1.93B
32 days until earnings call
Ad is loading...

PRME vs RXRX

Header iconPRME vs RXRX Comparison
Open Charts PRME vs RXRXBanner chart's image
Prime Medicine
Price$1.41
Change-$0.21 (-13.04%)
Volume$75.74K
Capitalization211.17M
Recursion Pharmaceuticals
Price$4.24
Change-$0.57 (-11.85%)
Volume$208.06K
Capitalization1.93B
PRME vs RXRX Comparison Chart
Loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRME vs. RXRX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRME is a Hold and RXRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (PRME: $1.61 vs. RXRX: $4.81)
Brand notoriety: PRME and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRME: 108% vs. RXRX: 74%
Market capitalization -- PRME: $211.17M vs. RXRX: $1.93B
PRME [@Biotechnology] is valued at $211.17M. RXRX’s [@Biotechnology] market capitalization is $1.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRME’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • PRME’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both PRME and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • PRME’s TA Score: 5 bullish, 2 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PRME is a better buy in the short-term than RXRX.

Price Growth

PRME (@Biotechnology) experienced а -19.50% price change this week, while RXRX (@Biotechnology) price change was -19.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

PRME is expected to report earnings on May 09, 2025.

RXRX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.93B) has a higher market cap than PRME($211M). RXRX YTD gains are higher at: -28.846 vs. PRME (-44.863). PRME has higher annual earnings (EBITDA): -196.34M vs. RXRX (-426.72M). RXRX has more cash in the bank: 594M vs. PRME (190M). PRME has less debt than RXRX: PRME (40.8M) vs RXRX (108M). RXRX has higher revenues than PRME: RXRX (58.5M) vs PRME (2.98M).
PRMERXRXPRME / RXRX
Capitalization211M1.93B11%
EBITDA-196.34M-426.72M46%
Gain YTD-44.863-28.846156%
P/E RatioN/AN/A-
Revenue2.98M58.5M5%
Total Cash190M594M32%
Total Debt40.8M108M38%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRMERXRX
RSI
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 5 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
83%
Momentum
ODDS (%)
Bullish Trend 5 days ago
80%
Bearish Trend 5 days ago
86%
MACD
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
86%
Advances
ODDS (%)
Bullish Trend 17 days ago
78%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 26 days ago
88%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
80%
Aroon
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
87%
View a ticker or compare two or three
Ad is loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-10.06%
CRSP - PRME
64%
Loosely correlated
-4.47%
NTLA - PRME
57%
Loosely correlated
-5.62%
RXRX - PRME
57%
Loosely correlated
-9.07%
BEAM - PRME
56%
Loosely correlated
-10.93%
ALLO - PRME
51%
Loosely correlated
-4.17%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-9.07%
CRSP - RXRX
69%
Closely correlated
-4.47%
BEAM - RXRX
62%
Loosely correlated
-10.93%
NTLA - RXRX
58%
Loosely correlated
-5.62%
PRME - RXRX
56%
Loosely correlated
-10.06%
ABSI - RXRX
53%
Loosely correlated
-9.88%
More